BSX stock: buy or sell?

BSX stock price: $42.73 1.38% At close on August 19th, 2019

Updated on:
August 19th, 2019


Boston Scientific shares appreciated 1.38% to $42.73 today. With Monday, it's been 3 green days in a row, adding $1.30 or 3.03%.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

Should I buy BSX stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at we prefer those that are simple but successful.

Currently, Boston Scientific stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Boston Scientific stock a buy?

Financial institutions and banks post stock ratings everyday. At, we collected 12 ratings published for BSX stock in the last 30 days.

The general sentiment of these ratings is bullish for BSX stock, with 9 positive ratings.
Is BSX a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-7-25Raymond Jamesn/aStrong-Buy
2019-6-27Stifel NicolausBuyIn-Line
2019-6-27Piper Jaffray Companiesn/aOverweight
2019-6-27Jefferies Financial GroupBuyPositive
2019-6-27Canaccord Genuityn/aBuy
2019-6-18Wells Fargo & Con/aOutperform
2019-2-8SunTrust Banksn/aBuy
2019-2-6Needham & Company LLCn/aBuy
2019-2-11Canaccord Genuityn/aBuy
2019-1-8Needham & Company LLCn/aBuy

BSX stock analysis

Daily outlook

Boston Scientific closed today at $42.73 and appreciated a decent 1.38%.

Boston Scientific closed today at $42.73 and appreciated a decent 1.38%. On May BSX price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. Since SMA50d and SMA100d crossed up on July, BSX price slid a -0.40%.

BSX stock chart (daily)

Weekly outlook

Shares of Boston Scientific closed this week at $42.73 and stepped up a tiny 1.38%.

BSX marked an uptrend of rising tops and rising bottoms. Since its last top early July at $43.66, price slid and bounced up back from $40.91. Breaking down under $40.91 would cancel the current uptrend and it might test lower supports. Note that $43.66 might act as a resistance line. By mid May BSX price bounced up over the SMA of 40 weeks that acted as support stopping new slides. Since late June when SMA10w and SMA20w crossed up, BSX price gained $1.04 per share (2.49%).

BSX stock chart (weekly)

BSX stock price history

BSX stock went public on May 19th, 1992 with a price of $4.251. Since then, BSX stock grew a 905.40%, with an average of 33.50% per year. If you had invested right after BSX's IPO a $1,000 in BSX stock in 1992, it would worth $9,054.00 today.

1: Adjusted price after possible price splits or reverse-splits.

BSX stock historical price chart

BSX stock reached 52-week highs on July at $43.66, and all-time highs 2004-04-06 with a price of 46.1.

BSX stock price target is $46.30

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we found 12 price forecasts for Boston Scientific stock:
BSX stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-7-25Raymond JamesRaises Target$48.00$50.004.2%
2019-6-27Stifel NicolausReiterates$44.00$46.004.5%
2019-6-27Piper Jaffray CompaniesRaises Target$42.00$50.0019%
2019-6-27Jefferies Financial GroupRaises Target$44.00$48.009.1%
2019-6-27Canaccord GenuityReiterates$43.00$46.007%
2019-6-18Wells Fargo & CoRaises Target$42.00$45.007.1%
2019-2-8SunTrust BanksReiteratesn/a$47.00-
2019-2-6Needham & Company LLCReiteratesn/a$43.00-
2019-2-13ArgusRaises Target$43.00$45.004.7%
2019-2-11Canaccord GenuityReiteratesn/a$45.00-
2019-1-8Needham & Company LLCReiteratesn/a$43.00-
(in average)$43.70$46.306.0%
Moving in a range from $50.00 and $43.00, the price prediction for Boston Scientific stock is $46.30. In average, analysts' outlook on BSX price forecast is positive, upgrading the forecast by a 6.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

Boston Scientific presented slightly good results for 2018-Q4 on February. Boston Scientific raised Earnings per Share (EPS) by 5.40%, beating analysts estimates of $0.37. Boston Scientific posted $0.39.
BSX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Boston Scientific annual sales rose a very good 8.57% to $9,823.00 million dollars from $9,048.00 marked in 2017. When comparing 2018 vs 2017, in the same way, profit margin (that is, the net income divided by revenues) climbed a 15.86% to 17.01%.

BSX annual Sales and Income evolution
2013$7,140 M-$-121.00 M-1.7%-
2014$7,380 M3.36%$-119.00 M-1.6%-1.65%
2015$7,477 M1.31%$-239.00 M-3.2%100.84%
2016$8,386 M12.16%$347 M4.1%-245.19%
2017$9,048 M7.89%$104 M1.1%-70.03%
2018$9,823 M8.57%$1,671 M17.0%1,506.73%

Quarterly financial results

Boston Scientific reported $2,561.00 M in revenues for 2018-Q4, a 7.02% improvement compared to previous quarter. Reported quarter income marked $386.00 million with a profit margin of 15.07%. Profit margin decreased a -2.98% compared to previous quarter when profit margin was 18.05%. When comparing turnover to same quarter last year, Boston Scientific sales marked a remarkable gain and soared a 6.35%.
BSX quarterly Sales and Income evolution
2017-Q2$2,260 M-$146 M6.5%-
2017-Q3$2,220 M-1.77%$283 M12.7%93.84%
2017-Q4$2,408 M8.47%$-615 M-25.5%-317.31%
2018-Q1$2,379 M-1.20%$298 M12.5%-148.46%
2018-Q2$2,490 M4.67%$555 M22.3%86.24%
2018-Q3$2,393 M-3.90%$432 M18.1%-22.16%
2018-Q4$2,561 M7.02%$386 M15.1%-10.65%
2019-Q1$2,493 M-2.66%$424 M17.0%9.84%

Boston Scientific ownership

When you are planning to invest in a company, it's worth to have a look its ownership structure.

Boston Scientific shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.25% of all shares.

Bearish positions for BSX stock account 0.00%, no big difference from last month.

For a better understanding, the next table shows ownership data compared to other related companies:

Market cap$59.4 B$707.2 M$2.7 B$45.6 B$0.0 M
Total shares1,390.0 M37.3 M28.3 M208.1 M0.0 M
Float shares1,390.0 M36.8 M27.6 M206.6 M1,340.0 M
  - Institutional holdings (%)93.4%102.5%97.5%0.0%84.2%
  - Insider holdings (%)0.2%2.5%1.8%3.9%0.1%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

BSX summary

Monday, August 19th, 2019
Day range$42.45 - $43.07
Previous close$42.15
Session gain1.38%
Average true range$1.08
50d mov avg$42.16
100d mov avg$39.86
200d mov avg$38.55
Daily pattern
Weekly pattern lb03a

Boston Scientific performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Boston Scientific against AngioDynamics, CONMED, Edwards Lifesciences, Medtronic, Merit Medical Systems, Stryker and Teleflex in the following table:
BSXBoston Scientific11.07%5.45%23.07%
EWEdwards Lifescien...26.70%23.38%56.93%
MMSIMerit Medical Sys...-34.09%-39.30%-36.13%

Boston Scientific competitors

One check before trading any stock is to review a list of its competitors, in this case for Boston Scientific. We chose 7 companies as Boston Scientific competitors as they are in the same industry or have similar market objectives.

Latest BSX stock news